Low-Dose Prasugrel vs. Standard-Dose Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention
0
Authors
Toshiki Kuno
Toshiki Kuno•Keiichi Fukuda•NULL AUTHOR_ID
Published
July 8, 2024
Abstract
Background: Low-dose prasugrel (3.75 mg) is used as maintenance therapy for percutaneous coronary intervention; however, data on long-term outcomes are scarce.
